SCHEMBL8287364

SCHEMBL8287364

O=c1cc(Nc2ccc(F)cc2)n(-c2ccc(F)cc2)c2nccc(C(F)(F)F)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.47
MEN1 O00255 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK10 P53779 1/20 0.35
AURKA O14965 4/20 0.34
CHEK2 O96017 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
FLT4 P35916 1/20 0.34
ABL2 P42684 1/20 0.34
BLK P51451 1/20 0.34
LIMK1 P53667 1/20 0.34
AURKB Q96GD4 1/20 0.34
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287096 0.87 PDE11A (0.60) PDE11AMEN1KMT2AAURKAGAA
SCHEMBL8287365 0.84 GRM5 (0.38) PDE11AMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL8287361 0.79 PDE11A (0.48) PDE11AALDH1A1MET
SCHEMBL8287120 0.79 PDE11A (0.49) PDE11AMAPK10GAAMDM2
SCHEMBL8287367 0.79 PDE11A (0.49) PDE11AMDM2
SCHEMBL8286090 0.77 PDE11A (0.48) PDE11AGAAMDM2METAXL
SCHEMBL8286091 0.77 PDE11A (0.46) PDE11AMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL8287391 0.76 PDE11A (0.81) PDE11ACYP3A4MAPK10
SCHEMBL8286094 0.74 PDE11A (0.45) PDE11AMEN1CYP1A2CYP3A4CYP2C19
SCHEMBL8286093 0.74 PDE11A (0.59) PDE11AMEN1KMT2AAURKAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed